98%
921
2 minutes
20
Background: High-flow nasal therapy is widely used in patients with respiratory failure in different clinical settings, but the effect of high-flow nasal therapy on respiratory-swallow coordination is unknown. Understanding this relationship is crucial, considering the necessity for patients to maintain adequate nutrition during daytime high-flow nasal therapy. This scoping review aims to synthesise available data on the effects of high-flow nasal therapy flow rates on swallowing function and the possible risk of aspiration during treatment, focusing on knowledge and evidence gaps.
Methods: PubMed, Scopus, Web of Science and Google Scholar databases were searched from inception to 30 May 2023 for studies reporting data on swallowing assessment in healthy adults or patients with acute or chronic respiratory failure receiving high-flow nasal therapy. Data on study design, patients' characteristics and quality outcomes were extracted.
Results: Eight studies were included, four including cohorts of healthy volunteers (n=148) and four including patients with acute or chronic respiratory failure (n=151). Study designs, patient populations and quality outcome measures were heterogeneous. Two studies indicated improvement while four articles showed impairment in swallowing function during high-flow nasal therapy; two studies showed that patients' overall clinical picture and underlying medical conditions influenced swallowing-breathing coordination rather than high-flow nasal therapy .
Conclusion: This scoping review found limited and controversial evidence on the impact of high-flow nasal therapy on swallowing function. Remarkably, methods for swallowing function assessment were quite heterogeneous. Additional research is required to test the effect of high-flow nasal therapy on respiratory-swallowing coordination.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11228606 | PMC |
http://dx.doi.org/10.1183/23120541.00075-2024 | DOI Listing |
J Pain Symptom Manage
September 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland and Department of Palliative Care Centre and Home Hospital Services, Tampere University Hospital, The Wellbeing Services County of Pirkanmaa, Finland.
Context: High-flow nasal therapy (HFNT) may relieve severe dyspnea, but its role compared to other treatment options in palliative care remains unclear.
Objectives: Assess the effect and feasibility of HFNT with air compared to fan therapy in relieving dyspnea among non-hypoxemic patients with incurable cancer.
Methods: This prospective, randomized, controlled, crossover trial compared airflow delivered by HFNT and fan.
Am J Vet Res
September 2025
Veterinary Emergency Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul, South Korea.
Objective: To determine whether high-flow nasal oxygen therapy (HFNOT) induces changes in esophageal pressure, a surrogate for intrathoracic pressure, and to evaluate the associated cardiovascular and respiratory effects in healthy dogs.
Methods: A prospective, randomized study was conducted in 6 healthy Beagles. Anesthesia was induced and maintained using alfaxalone total IV anesthesia.
Pediatr Int
September 2025
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Background: Administrative claims data are used in clinical studies; however, recorded diagnoses and procedures have not been fully validated for pediatric patients. We aimed to examine the validity of recorded information on pediatric patients in the Japanese Diagnosis Procedure Combination (DPC) database, a national inpatient database that includes administrative claims data.
Methods: We validated the DPC data using medical charts as the reference standard.
Eur J Pediatr
September 2025
Pediatric Infectious Diseases, Pediatric Emergency Care and Pediatric Ultrasound Department of Woman and Child Health and Public Health and Fondazione, Policlinico Universitario "A. Gemelli," , Rome, Italy.
Unlabelled: An increase in severe and invasive infections has been reported since the COVID-19 pandemic. However, most evidence comes from monocentric studies without nationwide representativeness. This multicenter, nationwide, retrospective study, conducted within the network of the Italian Society of Pediatric Infectious Diseases (SITIP), aimed to compare the severity of empyema at presentation in children (aged 1 month to 18 years) admitted to 19 Italian hospitals before, during, and after the pandemic.
View Article and Find Full Text PDFBMJ Open Respir Res
September 2025
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Background: We previously demonstrated a high prevalence of transpulmonary bubble transit (TPBT) using transcranial Doppler (TCD) in patients with COVID-19 pneumonia, but these observations require confirmation.
Methods: Patients at two academic medical centres, hospitalised with COVID-19 pneumonia and requiring any form of respiratory support, were studied. The first TCD study was performed at the time of enrolment and repeated approximately 7 and 14 days later if participants remained hospitalised.